Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2003
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356027A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/29/2003EP1356026A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP0889970B1 Novel plant enzyme and use thereof
10/29/2003EP0763105B1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0602193B1 Enhanced expression in plants
10/29/2003EP0293394B2 Novel thrombolytic proteins
10/29/2003CN1452659A Corynebacterium glutamicum genes encoding metabolic pathway proteins
10/29/2003CN1452657A Lubricated granules
10/29/2003CN1452656A Lipoxygenase
10/29/2003CN1451753A Technical scheme for increasing maricolous thermobacillus xylanase B gene expression level by large margin
10/29/2003CN1451751A Thermophilic esterase/phosphatidase gene, engrg. bacteria, enzyme and use thereof
10/29/2003CN1451746A Human profibrinolysin kringle 5 deletion mutation recombinant polypeptide
10/29/2003CN1451745A Natto kinase produced using Bacillus subtilis, and producing method and use thereof
10/29/2003CN1451744A Oriented culture method for increasing resistance of nitrile hydratase product
10/29/2003CA2382470A1 Mutant ndp kinases for antiviral nucleotide analog activation and therapeutic uses thereof
10/28/2003US6639130 Purified DNA encoding polypeptide having at least 50% identity of arabidopsis C-14
10/28/2003US6639127 Isolated and purified hop lupulin gland-specific promoter
10/28/2003US6639126 Production of modified polysaccharides
10/28/2003US6639125 Dull1 coding for a starch synthase and uses thereof
10/28/2003US6639054 Insecticidal proteins
10/28/2003US6639053 Screening using this gene or this RNA polymerase protein for inhibitors
10/28/2003US6638754 High throughput drug screening for antiproliferative agents; concurrent with fluorescent or absorbance readouts; microtubule-stimulated ATPase activity
10/28/2003US6638753 Genetically modified coryneform bacteria which code for cyclopropane-mycolic acid synthase and a method for the fermentative preparation of amino acids L-lysine and L-glutamate
10/28/2003US6638752 Biodetectors targeted to specific ligands
10/28/2003US6638751 Isolated human zinc protease proteins
10/28/2003US6638750 Diagnosing angiogenesis-related diseases; molecular hybridization, genetic engineering
10/28/2003US6638749 Carbon dioxide soluble surfactant having two fluoroether CO2-philic tail groups and a head group
10/28/2003US6638748 Nucleotide sequence coding enzymatic polypeptide for use in food processing
10/28/2003US6638747 Isolated polypeptide having specified amino acid sequence
10/28/2003US6638746 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use
10/28/2003US6638745 Antiinflammatory agents, anticarcinogenic agents; arteriosclerosis, psoriasis; gene therapy, diagnosis; genetic engineering
10/28/2003US6638744 Nuclelotide sequences coding enzymatic polypeptide for use in treatment of pain, inflamation, cancer, fever and osteoarthritis
10/28/2003US6638738 Peptide for use in human therapeutics and diagnostics
10/28/2003US6638737 Over-expressing in host cell to increase yield of secreted polypeptide; signal sequence at N-terminus and endoplasmic reticulum retention signal at C-terminus
10/28/2003US6638721 Human protein kinases and uses therefor
10/28/2003US6638720 Hybridization of probe as indication; transforming plants to impart resistance
10/28/2003US6638712 Isolated CLN2 protein having pepstatin-insensitive carboxyl protease activity; mutation or absence of CLN2 is causative of classical late infantile neuronal ceroid lipofuscinosis (LINCL)
10/28/2003US6638526 Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
10/28/2003US6638507 Antigen binding site of antibody; encoded by nucleic acids; diagnostic kits
10/28/2003US6638503 Extraction of actinokinase
10/28/2003US6638271 Multiple beam laser sculpting system and method
10/28/2003CA2189427C Subtilisin 309 variants having decreased adsorption and increased hydrolysis
10/28/2003CA2095109C Process for production of exogenous gene or its product in plant cells
10/23/2003WO2003088004A2 The cop protein design tool
10/23/2003WO2003087816A1 Crystals and structures of pak4kd kinase pak4kd
10/23/2003WO2003087393A2 Human tissue urokinase type plasminogen activator production
10/23/2003WO2003087386A2 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria
10/23/2003WO2003087381A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087379A1 Regulation of human protein kinase
10/23/2003WO2003087376A1 Caffeine synthase and use thereof
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087369A2 Ribozyme capable of specifically cleaving mmp-13
10/23/2003WO2003087354A2 Novel purified polypeptides involved in nucleotide transport and metabolism
10/23/2003WO2003087353A2 Purified polypeptides involved in membrane biogenesis
10/23/2003WO2003087352A2 Enolase polypeptides and structures
10/23/2003WO2003087341A2 Targeted chromosomal mutagenesis using zinc finger nucleases
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087332A2 Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
10/23/2003WO2003087325A2 Methods and compositions for preventing and treating microbial infections
10/23/2003WO2003087321A2 Plant acyl-coa synthetases
10/23/2003WO2003087301A2 Methods and compositions for dna manipulation
10/23/2003WO2003087299A2 Methods of characterizing molecular interaction sites on proteins
10/23/2003WO2003087149A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087146A2 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism
10/23/2003WO2003087145A2 Purified polypeptides involved in quorum sensing
10/23/2003WO2003087141A2 Adenine phosphoryltransferase from escherichia coli
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086338A1 Use of hydroxydiphenyl ether derivatives as arylsulfatase- inhibitors in deodorants and antiperspirants
10/23/2003WO2003086052A2 Low allergen plant and animal genotypes
10/23/2003WO2003060144A3 High fidelity dna polymerase compositions and uses therefor
10/23/2003WO2003055998A3 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase
10/23/2003WO2003054182A3 Production of butyrylcholinesterases in transgenic mammals
10/23/2003WO2003030825A3 CCAAT/ENHANCER BINDING PROTEIN-β (C/EBPβ IS A MOLECULAR TARGET FOR CANCER TREATMENT
10/23/2003WO2003025130A3 Receptors and membrane-associated proteins
10/23/2003WO2003000906A3 Plant disease resistance genes
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002089742A3 Heparin/heparosan synthase and methods of making and using same
10/23/2003WO2002079479A3 Motor proteins and methods for their use
10/23/2003WO2002079395A3 Carotenoid biosynthesis
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002070712A3 Chitin deacetylase and method for producing the same
10/23/2003WO2002070646A3 Matrix stabilized enzyme crystals and methods of use
10/23/2003WO2002068589A3 Enzymes having alpha amylase activity and methods of use thereof
10/23/2003WO2002055536A3 Regulation of target protein activity through modifier proteins
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002042465A8 Production of stilbenes in transgenic plants and the method of producing thereof
10/23/2003WO2001066763A9 23436, a human ubiquitin protease family member and uses thereof
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001029232A8 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
10/23/2003WO2001000879A8 Novel kinases and uses thereof
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
1 ... 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 ... 1416